Gilead Sciences, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2012 | $7.05B | $9.30B | $1.80B |
| FY2013 | $3.94B | $11.37B | $2.11B |
| FY2014 | $11.92B | $15.43B | $10.03B |
| FY2015 | $21.07B | $18.53B | $12.85B |
| FY2016 | $26.35B | $18.89B | $8.23B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2012 | $7.05B | $9.30B | $1.80B |
| FY2013 | $3.94B | $11.37B | $2.11B |
| FY2014 | $11.92B | $15.43B | $10.03B |
| FY2015 | $21.07B | $18.53B | $12.85B |
| FY2016 | $26.35B | $18.89B | $8.23B |